Total Valuation
MYUNGMOON Pharm Co., Ltd. has a market cap or net worth of ₩35.33B. The enterprise value is ―.
Market Cap₩35.33B
Enterprise Value―
Share Statistics
MYUNGMOON Pharm Co., Ltd. has 33,953,453 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,953,453
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MYUNGMOON Pharm Co., Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.58%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.58%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee631.87M
Profits Per Employee6.13M
Employee Count309
Asset Turnover0.72
Inventory Turnover2.27
Valuation Ratios
The current PE Ratio of MYUNGMOON Pharm Co., Ltd. is 13.3. MYUNGMOON Pharm Co., Ltd.’s PEG ratio is -0.20.
PE Ratio13.3
PS Ratio0.32
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-7.42
Price to Operating Cash Flow-27.87
PEG Ratio-0.20
Income Statement
In the last 12 months, MYUNGMOON Pharm Co., Ltd. had revenue of 195.25B and earned 1.90B in profits. Earnings per share was 56.70.
Revenue195.25B
Gross Profit107.19B
Operating Income6.83B
Pretax Income2.65B
Net Income1.90B
EBITDA10.13B
Earnings Per Share (EPS)56.70
Cash Flow
In the last 12 months, operating cash flow was -1.29B and capital expenditures -5.39B, giving a free cash flow of -6.67B billion.
Operating Cash Flow-1.29B
Free Cash Flow-6.67B
Free Cash Flow per Share-196.49
Dividends & Yields
MYUNGMOON Pharm Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.08
52-Week Price Change-32.62%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)734.97K
Important Dates
MYUNGMOON Pharm Co., Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
MYUNGMOON Pharm Co., Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 99.82%
Current Ratio0.96
Quick Ratio0.55
Debt to Market Cap1.56
Net Debt to EBITDA9.16
Interest Coverage Ratio1.34
Taxes
In the past 12 months, MYUNGMOON Pharm Co., Ltd. has paid 1.23B in taxes.
Income Tax1.23B
Effective Tax Rate0.46
Enterprise Valuation
MYUNGMOON Pharm Co., Ltd. EV to EBITDA ratio is 15.36, with an EV/FCF ratio of -18.39.
EV to Sales0.80
EV to EBITDA15.36
EV to Free Cash Flow-18.39
EV to Operating Cash Flow-91.32
Balance Sheet
MYUNGMOON Pharm Co., Ltd. has ₩4.56B in cash and marketable securities with ₩97.74B in debt, giving a net cash position of -₩93.18B billion.
Cash & Marketable Securities₩4.56B
Total Debt₩97.74B
Net Cash-₩93.18B
Net Cash Per Share-₩2.74K
Tangible Book Value Per Share₩3.06K
Margins
Gross margin is 56.48%, with operating margin of 3.50%, and net profit margin of 0.97%.
Gross Margin56.48%
Operating Margin3.50%
Pretax Margin1.36%
Net Profit Margin0.97%
EBITDA Margin5.19%
EBIT Margin3.50%
Analyst Forecast
The average price target for MYUNGMOON Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.94%
EPS Growth Forecast―